Successful root canal treatment could lower inflammation, blood sugar, and cholesterol, potentially reducing the risk of heart disease and type 2 diabetes, according to King’s College London research.
Multiple sclerosis (MS) is a disease that impacts the central nervous system, affecting everything we do. For many patients, the main question is: how do I confront this life-changing condition?
The World Health Organization (WHO) has certified Cabo Verde as a malaria-free country, marking a significant achievement in the global fight against the disease.
Scientists from the University of Liverpool and Liverpool School of Tropical Medicine (LSTM) have taken a huge step forward in combating the global threat of malaria.
35.3% of British adults are likely to have prediabetes. Dr Avinash Hari Narayanan (MBChB), Clinical Lead at London Medical Laboratory, argues that increased diabetes testing is needed to ensure 18 million people don’t go on to develop ‘full-blown’ diabetes.
Psoriasis is a chronic immune-mediated inflammatory disease that can impact sufferers’ mental and physical health. We discuss the complexity of the condition as well as the emergence of effective treatments with the national UK charity The Psoriasis Association.
Biologic therapies can effectively control severe asthma without the need for regular high-dose inhaled steroids, a significant revelation that could transform the lives of millions grappling with the condition.
The need for public health officials to be able to model the spread of an infectious disease has never been more apparent than in the early days of the SARS-CoV-2 pandemic.
Investigators from Brigham and Women's Hospital, have unveiled a pivotal connection between genetic changes in microglia, immune-regulating brain cells, and the inflammatory response associated with Alzheimer's disease (AD).
Michael Wong and Amy Campbell from the Physician-Patient Alliance for Health & Safety reflect on the fourth World Sepsis Congress discussion, which focused on ways to improve long-term health outcomes post sepsis.
A group of researchers around the globe have created a portable, non-invasive device capable of identifying biomarkers associated with Alzheimer's and Parkinson's disease.
Dr Tracey Pollard from RNID, the charity which supports the 12 million people in the UK who are deaf, have hearing loss or tinnitus, talks us through the causes and impact of hearing loss and how RNID is working to improve research and related treatments in this field.
Gillian Molloy, Director of Market Access at AscellaHealth, examines the rare disease landscape in the UK, including progress in improving patient care and challenges in diagnostics and the development of new treatments.
